Results 31 to 40 of about 5,333 (112)

New Insights on Respiratory Syncytial Virus Prevention

open access: yesVaccines, 2023
Respiratory syncytial virus (RSV) is a well-known infant pathogen transmitted mainly by droplets. It is a leading cause of upper respiratory tract infections in children, usually with a mild course of illness.
Edyta Kopera   +3 more
doaj   +1 more source

Resolution III Immunoprophylaxis Conference «Current Problems of Immunoprophylaxis in Russia»

open access: yesЭпидемиология и вакцинопрофилактика, 2023
23–24 ноября 2022 г. в рамках XIII Всероссийского конгресса пациентов «Вектор развития – пациент­-ориентированное здравоохранение», состоялась III Конференция «Актуальные проблемы иммунопрофилактики в России».
article Editorial
doaj  

Immunoprophylaxis of Respiratory Syncytial Virus Infection in Children

open access: yesПедиатрическая фармакология, 2015
The article is dedicated is to the issue of respiratory syncytial virus (RSV) infection in children. Urgency of this issue is beyond any doubt. RSV prevalence in the children hospitalized due to infections of lower airways is 18–33% in the advanced ...
A. A. Baranov   +6 more
doaj   +1 more source

Multidrug Resistance of F. tularensis subsp. holarctica, Epizootiological and Epidemiological Analysis of the Situation on Tularemia in the Russian Federation in 2022 and Forecast for 2023

open access: yesПроблемы особо опасных инфекций, 2023
The review provides concise information on the innate ability of cells of the tularemia pathogen, Francisella tularensis subsp. Holarctica, to resist antimicrobials through a variety of mechanisms, leading to its multi-resistance.
T. Yu. Kudryavtseva   +12 more
doaj   +1 more source

Tatochenko V. K., Ozeretskovsky N. A. Immunoprophylaxis 2020. (Reference book)

open access: yesЭпидемиология и вакцинопрофилактика, 2021
.
article Editorial
doaj  

Vaccinal Prevention of Pneumococcal Infection in Children

open access: yesПедиатрическая фармакология, 2015
It is known that before vaccination had been widely introduced pneumococcal infection was the cause of death of more than 1.5 mn people around the world annually, 40% of whom were infants.
A. A. Baranov   +8 more
doaj   +1 more source

Seroepidemiological study of pertussis in Henan Province, China, and prediction of the effectiveness of a new immunization strategy

open access: yesBiosafety and Health
The study objectives were to analyze the epidemiological characteristics of pertussis in Henan Province, China, and to evaluate the impact of pertussis vaccination strategy adjustments on population infection rates. A retrospective analysis was conducted
Yuting Tang   +5 more
doaj   +1 more source

Leprosy in children

open access: yesIndian Journal of Paediatric Dermatology, 2019
Children are believed to be the most vulnerable group to infection with Mycobacterium leprae due to their immature or nascent immunity and exposure to intrafamilial contacts.
Tarun Narang, Bhushan Kumar
doaj   +1 more source

Timely Birth Dose Vaccine to Prevent Vertical Transmission of Hepatitis B: A Single Center Experience on the Road to the WHO Elimination Goals in Italy

open access: yesVaccines, 2021
Italy was one of the first industrialized countries to implement a program of routine vaccination against hepatitis B virus (HBV) infection. However, currently, no HBV vaccine is administered at birth if the screened mother is HBsAg negative, whilst ...
Michele Pinon   +7 more
doaj   +1 more source

Pertussis: treatment goals and prevention options

open access: yesAktualʹnaâ Infektologiâ, 2018
The article deals with the questions of rational therapy and immunoprophylaxis of pertussis. It is shown that antibiotics can suppress cough only in incubational period and at prodromal stage as a result of B.pertussis eradication. At the spasmodic stage
V.V. Mavrutenkov, S.A. Kramarov
doaj   +1 more source

Home - About - Disclaimer - Privacy